Enovis to Participate in Upcoming Investor Conferences
12 août 2024 16h10 HE
|
Enovis Corporation
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Second Quarter 2024 Results
07 août 2024 06h00 HE
|
Enovis Corporation
Continued strong momentum with second-quarter sales growth of 23% on a reported basis and strong adjusted margin expansionReported second-quarter net loss from continuing operations of $0.34 per share...
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
25 juil. 2024 06h00 HE
|
Enovis Corporation
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming...
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
16 juil. 2024 07h00 HE
|
Enovis Corporation
Wilmington, DE, July 16, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
12 juil. 2024 08h00 HE
|
Enovis Corporation
AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today the...
Enovis to Participate in Upcoming Investor Conferences
10 mai 2024 06h00 HE
|
Enovis Corporation
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate...
Enovis Announces First Quarter 2024 Results
02 mai 2024 06h00 HE
|
Enovis Corporation
Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansionReported first-quarter net loss from continuing operations of $1.32 per share with adjusted...
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
17 avr. 2024 07h00 HE
|
Enovis Corporation
Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
28 mars 2024 07h00 HE
|
Enovis Corporation
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced...
Enovis Announces Fourth Quarter and Full Year 2023 Results
22 févr. 2024 06h00 HE
|
Enovis Corporation
Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of $0.05 per share with adjusted earnings per...